| |
|
|
|
|
|
|
|||
|
MA Williams, I Kouroumoussis, D Syndercombe-Court, L Hendry, AC Newland and SM Kelsey
Department of Haematology, London Hospital Medical College, Whitechapel,
UK.
Monocyte expression and secretion of tumor necrosis factor (TNF) and TNF
receptors (TNF-R) p55 and p75 was studied in patients receiving
granulocyte-macrophage colony-stimulating factor (GM-CSF) after intensive
chemotherapy. TNF expression and secretion of biologically active TNF was
increased at regeneration compared with that of patients who had received
chemotherapy alone. This effect persisted for several weeks after cessation
of growth factor therapy. GM-CSF restored the responsiveness of monocytes
to bacterial lipopolysaccharide (LPS), which appeared to be diminished
after chemotherapy alone. Expression and secretion of TNF-R p55 and p75 by
monocytes was augmented by GM-CSF therapy in association with the increase
in TNF protein. We propose that GM-CSF administration after chemotherapy
restores the normal responsiveness of monocytes to a secondary stimulus
such as LPS and primes monocytes to respond to LPS with increased
expression and secretion of TNF and TNF-R.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1995 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||